Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
ClinicalTrials.gov study NCT04739670. IPD Sharing: YES. Countries: 1. Publications: 0.
A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer
ClinicalTrials.gov study NCT01042028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT00139971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That
ClinicalTrials.gov study NCT03321643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
ClinicalTrials.gov study NCT06457503. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas
ClinicalTrials.gov study NCT01800630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT07107750. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC
ClinicalTrials.gov study NCT00463515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT06454383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas
ClinicalTrials.gov study NCT00490399. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
ClinicalTrials.gov study NCT00003797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery
ClinicalTrials.gov study NCT06050252. IPD Sharing: YES. Countries: 1. Publications: 0.
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00066768. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer
ClinicalTrials.gov study NCT04669197. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
ClinicalTrials.gov study NCT02754180. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
ClinicalTrials.gov study NCT00201305. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
ClinicalTrials.gov study NCT02050178. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer
ClinicalTrials.gov study NCT00696579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer
ClinicalTrials.gov study NCT00192062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
ClinicalTrials.gov study NCT01593475. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.